News
British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...
The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.
GSK shares fell more than 6% on Friday to the bottom of Britain's blue-chip index after a U.S. FDA advisory panel recommended ...
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...
The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...
The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage ...
Explore more
GSK has failed to win the backing of influential advisers to the US drugs regulator for a key blood cancer drug, putting its ...
GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom ...
GSK PLC closed 16.45% short of its 52-week high of £16.79, which the company reached on September 9th.
GSK Plc shares tumbled after its blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting ...
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug ...
Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results